NAGSD is the only urea cycle disorder that can be treated with a single drug, N-carbamylglutamate (NCG), which can activate CPS1 and completely restore ureagenesis in patients with NAGSD. This evidence concerns the gene CPS1 and hyperammonemia due to N-acetylglutamate synthase deficiency.